Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
Go back to Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial| Bemis Company (NYSE: BMS) | Delayed: 57.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.25 | 52 Week High | $54.19 | |||
| Open | $68.29 | 52 Week Low | $42.45 | |||
| Day High | $57.25 | P/E | 28.06 | |||
| Day Low | $57.25 | EPS | $2.04 | |||
| Volume | 85,365 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.92 +0.11 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.81 | 52 Week High | $77.12 | |||
| Open | $67.58 | 52 Week Low | $49.03 | |||
| Day High | $68.04 | P/E | 43.45 | |||
| Day Low | $66.65 | EPS | $1.54 | |||
| Volume | 6,933,454 | |||||
| (NYSE: RCUS) | Delayed: 29.71 +0.43 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.28 | 52 Week High | $ | |||
| Open | $29.18 | 52 Week Low | $ | |||
| Day High | $29.87 | P/E | N/A | |||
| Day Low | $28.68 | EPS | $ | |||
| Volume | 1,528,495 | |||||

